Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study
Year: 2001
Type: article
Source: Lung Cancer
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G1072356872, G10814802, CANCER AND LEUKEMIA GROUP B, G1391839138, WUMC Cancer and Leukemia Group B, G1486637521, G152477846, CANCER AND LEUKEMIA GROUP B, G1683477986, G1689128559, G211333722, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B, G2296793909, G237383067, G2405064429, COMMUNITY CLINICAL ONCOLOGY PROGRAM, G257334932, G260759372, Cancer and Leukemia Group B, G2647518335, G2699437999, Cancer and Leukemia Group B Statistical Center, University of Iowa CALGB Institutional Grant, Southeast Cancer Control Consortium, Inc, CANCER AND LEUKEMIA GROUP B--MOUNT SINAI, G3710026009, G4192246825, G4530377164, G4670716055, G4744150602, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B: RPMI/SUNYAB, G532797959, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B, CANCER AND LEUKEMIA GROUP B (CALGB), GREEN MOUNTAIN ONCOLOGY GROUP, CANCER AND LEUKEMIA GROUP B, Delaware/Christiana Care Community Clinical Oncology Program, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, Hematology-Oncology Associates of Central New York CCOP, CANCER AND LEUKEMIA GROUP B, G739544170, CANCER AND LEUKEMIA GROUP B--MINNESOTA ONCOLOGY GROUP, Cancer and Leukemia Group B, Nevada Cancer Research foundation-Community Clinical Oncology Program, G7991221340, CANCER AND LEUKEMIA GROUP B, G866232813, G877081928, G877907214, G926666752, G973482110, G979369470
OpenAlex ID: W2028837881
